MCRI On-X Prosthetic Valve Approved For Mitral Indication
This article was originally published in The Gray Sheet
Executive Summary
Medical Carbon Research Institute plans to begin shipping its On-X prosthetic mitral heart valve by May, following supplemental PMA approval on March 6
You may also be interested in...
MCRI On-X Mechanical Heart Valve Gains Aortic Indication
The Medical Carbon Research Institute will not have to perform post-market studies for its On-X prosthetic heart valve, which gained premarket approval from FDA on May 30.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.